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We report a 38-year-old Chinese woman with lupus nephritis on
peritoneal dialysis and long-term maintenance steroid therapy. This
patient developed paradoxical deterioration during anti-tubercular
therapy for tuberculous lymphadenitis. The deterioration resolved
spontaneously without change to pharmacotherapy. Paradoxical
deterioration that may spontaneously resolve is a potential compli-
cation of anti-tubercular treatment in patients on long-term renal
replacement therapy.
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Introduction
Paradoxical deterioration during anti-tubercular therapy refers to the
clinical or radiological worsening of pre-existing tuberculous lesions or
the development of new lesions not attributable to the normal course of
disease in a patient who initially improves with anti-tubercular therapy.1
This phenomenon is more commonly associated with extrapulmonary
tuberculosis.2 There is no specific diagnostic test for such paradoxical
deterioration, although a surge in lymphocyte count is suggestive of such
a diagnosis.2,3 Paradoxical worsening during treatment for tuberculosis
has been extensively reported in AIDS patients, particularly following
therapy with highly active antiretroviral agents.3-5 It is also well recog-
nised in patients without HIV infection.1,2,6-8
Patients with chronic renal failure are more prone to opportunistic
infections, including tuberculosis.9-11 In patients undergoing continuous
ambulatory peritoneal dialysis (CAPD), the prevalence of tuberculosis is
several times higher than that of the general population.10 Nonetheless, a
paradoxical response during anti-tubercular therapy has not been reported
in such patients and has not, apparently, been previously described in
patients receiving long-term steroid therapy. We report a patient with
underlying lupus nephritis on CAPD and maintenance steroid therapy
who demonstrated a paradoxical deterioration during treatment for
tuberculous lymphadenitis.
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Case report
The patient was a 38-year-old Chinese woman with
end-stage renal failure secondary to lupus nephritis who
commenced haemodialysis in 1995. In March 2002,
she switched to CAPD because of failed vascular
access. A history of cerebral lupus was noted for
which long-term maintenance steroid therapy was
prescribed (prednisolone 5 mg daily). Lupus activity
had been clinically and serologically inactive follow-
ing commencement of renal replacement therapy.
In September 2002, the patient presented with
fever and appearance of a left upper neck swelling.
Physical examination revealed enlarged left upper
cervical lymph nodes. No other lymph nodes were
affected, nor were the liver or spleen. Preliminary
investigations revealed the following: normal total
white cell count (4.4 x 109 /L) with relative lympho-
penia (0.6 x 109 /L), haemoglobin level of 67 g/L, and
platelet count of 90 x 109 /L. Erythrocyte sedimenta-
tion rate was 32 mm/h and C-reactive protein was
elevated at 34.4 mg/L (reference level, <7.6 mg/L).
Serum electrolytes and liver function tests were un-
remarkable. Serum albumin and globulin levels were
23 g/L and 40 g/L, respectively. Her lupus serology
was quiescent: antinuclear factor titre 1/160, anti-DNA
titre less than 1 IU/mL (reference range, 0-35 IU/mL),
complement levels normal (C3, 1140 mg/L [reference
range, 760-1500 mg/L]; C4, 300 mg/L [reference
range, 90-350 mg/L]). She was seronegative for HIV.
Chest radiography revealed clear lung fields and nasal
endoscopy was normal. Fine needle aspiration of the
left cervical lymph node yielded several millilitres of
pus-like material. Smear examination and culture of
the aspirate was negative for bacteria and acid-fast
bacilli. Cytology was negative. Excisional biopsy of
the cervical lymph node revealed granuloma formation,
extensive caseous necrosis, and the presence of acid-
fast bacilli by Ziehl-Neelsen stain. A diagnosis of
tuberculous lymphadenitis was made and the patient
was given supervised anti-tubercular therapy (daily
doses of isoniazid 200 mg, rifampicin 450 mg, pyrazi-
namide 1.5 g, levofloxacin 200 mg, and pyridoxine
100 mg). Cultures of the aspirate and excisional
biopsy from the left cervical lymph node subsequently
yielded Mycobacterium tuberculosis that was
sensitive to standard anti-tubercular drugs. The patient
was maintained on the existing 5 mg per day oral
prednisolone. The enlarged cervical lymph nodes
decreased in size after the initiation of anti-tubercular
therapy, but increased again along with tender right
axillary lymphadenopathy 2 weeks later. Total white
cell count at the time was normal but lymphocyte
count had increased to 1.4 x 109 /L. Fine needle aspi-
ration of the right axillary lymph node revealed acid-
fast bacilli on smear, although subsequent bacterial
culture was negative. Lupus serology remained stable
and a provisional diagnosis was made of paradoxical
deterioration. Anti-tubercular and steroid therapy was
continued. Cervical and right axillary lymph nodes
decreased in size after a week and completely resolved
3 weeks later, and the patient’s general condition
gradually improved. Anti-tubercular drug therapy was
completed uneventfully and maintenance steroid
therapy continued.
Discussion
We report a lupus patient on CAPD and maintenance
steroid therapy who developed paradoxical deteriora-
tion during treatment for tuberculous lymphadenitis.
The paradoxical deterioration resolved spontaneously
with continuation of anti-tubercular drugs and with no
change in steroid dosage.
Paradoxical deterioration during anti-tubercular
treatment is diagnosed by exclusion. Enlargement of
cervical lymph nodes and appearance of new enlarged
lymph nodes in the axilla after initial improvement on
anti-tubercular therapy suggests a number of differen-
tial diagnoses: inadequate anti-tubercular treatment
due to drug resistance or poor drug compliance, con-
comitant bacterial infection, and, rarely, re-activation
of lupus activity.12 Nonetheless, supervision of anti-
tubercular therapy together with biochemical and
microbiological testing excluded them all. The
demonstration of acid-fast bacilli on direct smear but
not from culture of the patient’s axillary lymph node
aspirate indicated that the acid-fast bacilli were not
viable after 2 weeks of anti-tubercular treatment. This,
together with the spontaneous resolution of lymph-
adenopathy while continuing anti-tubercular treatment,
suggested a diagnosis of paradoxical deterioration. The
surge in lymphocyte count during the time of apparent
clinical deterioration further supported this diagnosis.
Paradoxical deterioration during anti-tubercular
treatment is not uncommon. The prevalence of para-
doxical deterioration among HIV-negative patients
during treatment for tuberculosis has been recently
reported at 11.1%.2 Tuberculosis is also common
among patients with chronic renal insufficiency,9-11 but
paradoxical deterioration has not previously been
reported. It is possible that patients on dialysis are
less prone to develop paradoxical responses: the host
immune responses of such patients are altered and
there is a high rate of anergy.13-15
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The pathogenesis of paradoxical deterioration
during anti-tubercular treatment remains to be fully
elucidated. It may be related to the development of
enhanced immunological responses against M
tuberculosis during the course of anti-tubercular
therapy.16,17 In HIV-infected patients who develop
paradoxical deterioration during anti-tubercular treat-
ment after having received highly active antiretroviral
therapy, clinical deterioration may be due to the im-
mune reconstitution inflammatory syndrome, an exu-
berant inflammatory response towards the incubating
Mycobacterium.18 Corticosteroids have been prescribed
to treat paradoxical deterioration.7 Interestingly this
offered no protection for the patient reported here.
The dose was nonetheless small and might have been
insufficient to entirely suppress the inflammatory
response. The concomitant administration of isoniazid
might also have reduced the effectiveness of the steroid.
There is no consensus on the optimal treatment for
paradoxical deterioration during anti-tubercular
treatment. The condition may be self-limiting as
demonstrated by our patient. An expectant approach
is probably called for with the continuation of anti-
tubercular and pre-existing steroid therapy. Such an
approach will also avoid the problem of side-effects
associated with high-dose steroid therapy.
Paradoxical deterioration during anti-tubercular
treatment can occur in CAPD patients on maintenance
steroid therapy. Although self-limiting, clinicians
should recognise this potential complication. In the
absence of other causes of clinical deterioration, spon-
taneous resolution can be expected with no change
required to any anti-tubercular or other concomitant
pharmacotherapy.
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